biote Corp.
BTMDNASDAQHealthcare● Active
$2.39
+$0.05(+1.92%)
Market Cap$105196476
P/E Ratio—
52W High$4.75
52W Low$1.27
biote Corp. (BTMD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BTMD · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
$0.06
Est. $0.09 · -33.3%
Revenue
$0.04B
Est. $0.05B · -2.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
BTMD reports quarterly as a NASDAQ-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | $0.07 | — | — | — | $0.05B | — |
| ▼ Q2 FY2026 | May 6, 2026 | $0.09 | $0.06 | -33.3% | $0.04B | $0.05B | -2.4% |
| ▲ Q1 FY2026 | Mar 11, 2026 | $0.05 | $0.06 | +20.0% | $0.05B | $0.05B | +1.3% |
| ▲ Q4 FY2025 | Nov 5, 2025 | $0.05 | $0.22 | +340.0% | $0.05B | $0.05B | +4.7% |
| ▲ Q3 FY2025 | Aug 6, 2025 | $0.06 | $0.10 | +66.7% | $0.05B | $0.05B | +2.3% |
| ▲ Q2 FY2025 | May 7, 2025 | $0.06 | $0.08 | +33.3% | $0.05B | $0.05B | +3.7% |
| ▲ Q1 FY2025 | Mar 12, 2025 | $0.09 | $0.10 | +11.1% | $0.05B | $0.05B | -6.8% |
| ▲ Q4 FY2024 | Nov 12, 2024 | $0.09 | $0.33 | +266.7% | $0.05B | $0.05B | +0.4% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
$0.07
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Miss
EPS Actual
$0.06
EPS Est.
$0.09
EPS Surpr.
-33.3%
Revenue
$0.04B
Q1 FY2026
Mar 11, 2026Beat
EPS Actual
$0.06
EPS Est.
$0.05
EPS Surpr.
+20.0%
Revenue
$0.05B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
$0.22
EPS Est.
$0.05
EPS Surpr.
+340.0%
Revenue
$0.05B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
$0.10
EPS Est.
$0.06
EPS Surpr.
+66.7%
Revenue
$0.05B
Q2 FY2025
May 7, 2025Beat
EPS Actual
$0.08
EPS Est.
$0.06
EPS Surpr.
+33.3%
Revenue
$0.05B
Q1 FY2025
Mar 12, 2025Beat
EPS Actual
$0.10
EPS Est.
$0.09
EPS Surpr.
+11.1%
Revenue
$0.05B
Q4 FY2024
Nov 12, 2024Beat
EPS Actual
$0.33
EPS Est.
$0.09
EPS Surpr.
+266.7%
Revenue
$0.05B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.12 | $0.13 | $0.13 | 1 |
| Q3 FY2027 | $0.11 | $0.11 | $0.11 | 1 |
| Q2 FY2027 | $0.08 | $0.08 | $0.08 | 1 |
| Q1 FY2027 | $0.10 | $0.10 | $0.10 | 1 |
| Q4 FY2026 | $0.10 | $0.10 | $0.10 | 1 |
| Q3 FY2026 | $0.07 | $0.07 | $0.07 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 3 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q2 FY2027 | $0.0B | $0.1B | $0.1B | 2 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q4 FY2026 | $0.0B | $0.1B | $0.1B | 3 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 6, 2026 | -33.3% | $2.21 | $2.20 | -0.45% |
| ▲ Q1 FY2026 | Mar 11, 2026 | +20.0% | $1.70 | $1.72 | +1.18% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +340.0% | $2.86 | $2.93 | +2.45% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +66.7% | $4.17 | $3.86 | -7.43% |
| ▲ Q2 FY2025 | May 7, 2025 | +33.3% | $3.37 | $3.34 | -0.89% |
| ▲ Q1 FY2025 | Mar 12, 2025 | +11.1% | $4.13 | $4.10 | -0.73% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +266.7% | $5.75 | $5.52 | -4.00% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +55.6% | $6.97 | $6.77 | -2.87% |
Q2 FY2026-0.45%
Report Date
May 6, 2026
EPS Beat/Miss
-33.3%
Price Before
$2.21
Price After
$2.20
Q1 FY2026+1.18%
Report Date
Mar 11, 2026
EPS Beat/Miss
+20.0%
Price Before
$1.70
Price After
$1.72
Q4 FY2025+2.45%
Report Date
Nov 5, 2025
EPS Beat/Miss
+340.0%
Price Before
$2.86
Price After
$2.93
Q3 FY2025-7.43%
Report Date
Aug 6, 2025
EPS Beat/Miss
+66.7%
Price Before
$4.17
Price After
$3.86
Q2 FY2025-0.89%
Report Date
May 7, 2025
EPS Beat/Miss
+33.3%
Price Before
$3.37
Price After
$3.34
Q1 FY2025-0.73%
Report Date
Mar 12, 2025
EPS Beat/Miss
+11.1%
Price Before
$4.13
Price After
$4.10
Q4 FY2024-4.00%
Report Date
Nov 12, 2024
EPS Beat/Miss
+266.7%
Price Before
$5.75
Price After
$5.52
Q3 FY2024-2.87%
Report Date
Aug 8, 2024
EPS Beat/Miss
+55.6%
Price Before
$6.97
Price After
$6.77
Avg Beat Reaction-1.76%
Avg Miss Reaction-0.45%
Beat Rate7 / 8 quarters
Largest Move-7.43% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BTMD ends December
biote Corp. (BTMD) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $0.06 — missing the analyst consensus of $0.09 by -33.3%. The next BTMD earnings date is expected around September 1, 2026.
Each quarter, investors track BTMD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BTMD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BTMD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BTMD earnings · 5 questionsbiote Corp.'s next earnings report is expected around September 1, 2026. BTMD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BTMD historically reports after market close (AMC).
BTMD earnings datewhen is BTMD earningsBTMD next earnings datewhen does BTMD report earningsBTMD earnings calendar
▸ Source: FMP · biote Corp. SEC filings · US GAAP · biote Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026